ArticleAmerican journal of cardiovascular drugs : drugs, devices, and other interventions2021
Ex Ante Economic Evaluation of Arg389 Genetically Targeted Treatment with Bucindolol versus Empirical Treatment with Carvedilol in NYHA III/IV Heart Failure.
Nimer Alkhatib et al.PubMed ↗Publisher ↗
No numbers read from the abstract.